Medical management of ulcerative colitis.
Patients with ulcerative colitis have no increased mortality compared to population controls and the disease can be cured be colectomy. This review concentrates on the medical management of ulcerative colitis including the management of active colitis, acute severe colitis and first presentation of colitis, maintenance of remission and long-term complications.
Thuraisingam
Adrian
A
Department of Gastroenterology, Royal Liverpool and Broadgreen University Hospitals, Liverpool L7 8XP.
Leiper
Keith
K
D000208:Acute Disease; D000284:Administration, Oral; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D003110:Colonic Neoplasms / Q000209:etiology; D016572:Cyclosporine / Q000627:therapeutic use; D004815:Epidermal Growth Factor / Q000627:therapeutic use; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D000069285:Infliximab; D019936:Probiotics / Q000627:therapeutic use; D011687:Purines / Q000627:therapeutic use; D012307:Risk Factors; D013256:Steroids / Q000008:administration & dosage
D000636:Aminosalicylic Acids; D000900:Anti-Bacterial Agents; D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D011687:Purines; D013256:Steroids; D004815:Epidermal Growth Factor; D016572:Cyclosporine; D006493:Heparin; D000069285:Infliximab